| Li, Guoqing |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
| Li, Xin |
| Active, not recruiting | 4 | 948 | Europe, Canada, US, RoW | Edoxaban, Lixiana, Savaysa, Non-anticoagulant medical therapy | Population Health Research Institute | Intracranial Hemorrhages, Atrial Fibrillation | 04/26 | 10/26 | | |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
NCT04025164: Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery |
|
|
| Recruiting | 3 | 4052 | RoW | Hypofractionated Radiotherapy, Experimental Arm, Conventional fractionated Radiotherapy, Standard Arm | Fudan University | Breast Cancer | 06/23 | 06/28 | | |
NCT05003245: Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD |
|
|
| Recruiting | 3 | 388 | RoW | HLX04-O，recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection, Lucentis | Shanghai Henlius Biotech | Age Related Macular Degeneration | 08/23 | 03/24 | | |
NCT05525637: Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder |
|
|
| Recruiting | 3 | 1041 | RoW | YZJ-1139 20mg, YZJ-1139 40mg, Placebo | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Insomnia Disorder | 12/24 | 12/24 | | |
| Recruiting | 3 | 357 | Europe, Japan, US, RoW | Belantamab mafodotin, Pomalidomide, Dexamethasone, Bortezomib | GlaxoSmithKline | Multiple Myeloma | 01/24 | 05/29 | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Recruiting | 2 | 120 | RoW | TQH3906 capsules, Placebo of TQH3906 capsules | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Plaque Psoriasis | 01/25 | 09/25 | | |
NCT06601504: Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL |
|
|
| Recruiting | 2 | 60 | RoW | HMPL-760 planned dose 1, R-GemOx, Rituximab Injection, Gemcitabine Hydrochloride for Injection, Gemcitabine Hydrochloride for Injection, HMPL-760 placebo planned dose 1, HMPL-760 planned dose 2, HMPL-760 placebo planned dose 2 | Hutchmed | Relapsed/Refractory Diffuse Large B-Cell Lymphoma | 05/26 | 11/26 | | |
NCT05768529: Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma |
|
|
| Recruiting | 1/2 | 100 | RoW | U16 | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | Relapsed or Refractory Non-Hodgkin's Lymphoma | 12/24 | 12/26 | | |
NCT04673799: Comparing of the Pharmacokinetics, Immunogenicity and Safety of MV088 and Prolia® in Healthy Adults. |
|
|
| Not yet recruiting | 1 | 144 | NA | MV088 injection, Prolia® injection | Kunming Pharmaceuticals, Inc. | Healthy | 10/21 | 10/21 | | |
| Completed | 1 | 100 | RoW | AK104 (before the change), AK104 (after the change) | Akeso | Healthy Male Subjects | 03/23 | 04/23 | | |
NCT05758428: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Nebulized Ensifentrine in Healthy Chinese Subjects |
|
|
| Completed | 1 | 28 | RoW | Ensifentrine, Placebo | Nuance Pharma (shanghai) Co., Ltd | Chronic Obstructive Pulmonary Disease | 04/23 | 04/23 | | |
GNC-035-103, NCT05160545: A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Breast Cancer |
|
|
| Recruiting | 1 | 29 | RoW | GNC-035 | Sichuan Baili Pharmaceutical Co., Ltd., Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. | Breast Cancer | 06/25 | 12/25 | | |
| Recruiting | 1 | 152 | RoW | Recombinant CD20 monoclonal antibody-MMAE conjugte for injection, TRS005 | Zhejiang Teruisi Pharmaceutical Inc. | CD20-positive B-cell Non-Hodgkin Lymphoma | 12/23 | 12/24 | | |
NCT05505812: Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Breast Cancer |
|
|
| Not yet recruiting | 1 | 10 | RoW | HS-IT101 | The Affiliated Hospital of Qingdao University, Qingdao Sino-Cell Biomedicine Co.,Ltd. | Breast Cancer | 12/23 | 03/27 | | |
| Not yet recruiting | 1 | 12 | RoW | NTQ5082 capsule | Nanjing Chia-tai Tianqing Pharmaceutical | Complement-mediated Hemolytic Diseases | 12/24 | 02/25 | | |
NCT06560593: A Phase 1 Clinical Trial of NTQ5082 in Healthy Volunteers |
|
|
| Not yet recruiting | 1 | 82 | RoW | NTQ5082, Placebo | Nanjing Chia-tai Tianqing Pharmaceutical | Complement-mediated Hemolytic Diseases | 12/24 | 02/25 | | |
NCT06196060: Improving ToM in Children With ASD Through VPT Training: Behavioral and fNIRS Study |
|
|
| Recruiting | N/A | 100 | RoW | Visual perspective taking training, Block building training, Thought-bubble training, Treatment as usual | Nanjing Normal University, Zhuhai Fudan Innovation Institute, Second Affiliated Hospital of Guangxi Medical University | Autism Spectrum Disorder | 06/24 | 09/24 | | |
NCT06579976: Multimodal High-frequency Ultrasound-based Study of Plaque Psoriasis Severity Index |
|
|
| Not yet recruiting | N/A | 45 | RoW | No intervention | Shanghai Yueyang Integrated Medicine Hospital | Plaque Psoriasis | 02/25 | 05/25 | | |
NCT05665010: Precise Stratification of Genetic Risk of Ovarian Function Impairment |
|
|
| Recruiting | N/A | 1000 | RoW | Genetic susceptibility | Tongji Hospital | Premature Ovarian Insufficiency, Diminished Ovarian Reserve, Early Menopause | 10/23 | 10/24 | | |
| Wang, Zhao |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
NCT02633176: Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma |
|
|
| Recruiting | 3 | 120 | RoW | Cetuximab, Erbitux, Cisplatin, Docetaxel, Taxotere, Capecitabine, Xeloda, Radiotherapy | Sun Yat-sen University, Chinese Southwest Oncology Group | Nasopharyngeal Carcinoma | 01/23 | | | |
| Completed | 3 | 16 | RoW | Zanubrutinib | Beijing Friendship Hospital | HLH | 08/23 | 08/23 | | |
| Recruiting | 3 | 30 | RoW | Rituximab Monotherapy | Beijing Friendship Hospital | Secondary Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection | 02/24 | 04/24 | | |
NCT05438875: The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9 |
|
|
| Recruiting | 3 | 96 | RoW | all-trans retinoic acid, retinoic acid, Eltrombopag, TPO-RA | Peking University People's Hospital, Beijing Friendship Hospital, Beijing Tongren Hospital, Beijing Hospital, Navy General Hospital, Beijing | Purpura, Thrombocytopenic, Idiopathic | 12/24 | 03/25 | | |
NCT05775705: L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH |
|
|
| Not yet recruiting | 3 | 25 | RoW | L-DEP and PD-1 antibody | Beijing Friendship Hospital | PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus, Lymphoma | 08/26 | 10/26 | | |
NCT06176235: Teriflunomide Plus High-dose Dexamethasone as First-line Treatment in Newly Diagnosed Primary Immune Thrombocytopenia |
|
|
| Recruiting | 2 | 132 | RoW | Teriflunomide, AUBAGIO, Dexamethasone | Peking University People's Hospital, Beijing Luhe Hospital, Chinese PLA General Hospital, Navy General Hospital, Beijing, Beijing Hospital, Beijing Friendship Hospital, Peking University First Hospital, Peking University Third Hospital, China-Japan Friendship Hospital, Beijing Tsinghua Changgeng Hospital | Immune Thrombocytopenia | 12/24 | 05/25 | | |
NCT05716087: A Study of Rocbrutinib in Participants with Relapse or Refractory Mantle Cell Lymphoma |
|
|
| Active, not recruiting | 2 | 62 | RoW | Rocbrutinib, NWP-775, LP-168 | Guangzhou Lupeng Pharmaceutical Company LTD. | Mantle Cell Lymphoma (MCL) | 12/24 | 12/25 | | |
NCT04849351: Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma |
|
|
| Recruiting | 2 | 185 | RoW | HMPL-689, Phosphatidylinositol 3-kinase-δ inhibitor | Hutchison Medipharma Limited | Marginal Zone Lymphoma, Follicular Lymphoma | 04/24 | 12/24 | | |
NCT05932524: Low-dose Baricitinib Plus High-dose Dexamethasone for Patients With Newly Diagnosed Immune Thrombocytopenia |
|
|
| Recruiting | 2 | 132 | RoW | Baricitinib 2 MG, Olumiant, Dexamethasone, HD-DXM | Peking University People's Hospital, Beijing Luhe Hospital, Chinese PLA General Hospital, Navy General Hospital, Beijing, Beijing Hospital, Beijing Friendship Hospital, Peking University First Hospital, Peking University Third Hospital, China-Japan Friendship Hospital, Beijing Tsinghua Changgeng Hospital | Immune Thrombocytopenia | 06/24 | 06/25 | | |
NCT05852847: Low-dose Baricitinib Plus Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia |
|
|
| Recruiting | 2 | 216 | RoW | Baricitinib 2 MG [Olumiant], Olumiant, Danazol | Peking University People's Hospital, Beijing Luhe Hospital, Chinese PLA General Hospital, Navy General Hospital, Beijing, Beijing Hospital, Beijing Friendship Hospital, Peking University First Hospital, Peking University Third Hospital, China-Japan Friendship Hospital, Beijing Tsinghua Changgeng Hospital | Immune Thrombocytopenia | 11/24 | 05/25 | | |
NCT04326348: A Study of TQ05105 Tablets in Subjects With Hemophagocytic Lymphohistiocytosis（HLH） |
|
|
| Recruiting | 1 | 40 | RoW | TQ05105 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Hemophagocytic Lymphohistiocytosis | 01/22 | 07/22 | | |
NCT05155839: Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL) |
|
|
| Recruiting | 1 | 108 | RoW | MRG001 | Shanghai Miracogen Inc. | Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL) | 10/22 | 10/23 | | |
| Not yet recruiting | 1 | 20 | RoW | toripalimab injection, EBV-DNA positive | Beijing Friendship Hospital | PD-1, EBV Infection, Transplant | 01/23 | 01/23 | | |
NCR300-2002, NCT06441084: A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After Transplantation |
|
|
| Not yet recruiting | 1 | 15 | NA | NCR300 injection | Nuwacell Biotechnologies Co., Ltd., Beijing Friendship Hospital | Acute Myeloid Leukemia | 12/28 | 12/31 | | |
NCT05477446: Safety and Efficacy of CD207 Targeted CAR-T Cell Therapy in Patients With R/R Langerhans Cell Histiocytosis |
|
|
| Not yet recruiting | 1 | 12 | RoW | CD207 CAR-T cells | Beijing Friendship Hospital, Beijing Boren Hospital | Langerhans Cell Histiocytosis | 06/25 | 08/25 | | |
NCT05546060: Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLH |
|
|
| Recruiting | 1 | 20 | RoW | Venetoclax, Dexamethasone, Etoposide | Beijing Friendship Hospital | Hemophagocytic Lymphohistiocytosis | 07/25 | 10/25 | | |
NCT04500886: Evaluate the Efficacy and Safety of PEG-rhG-CSF in Patients With Hemophagocytic Syndrome |
|
|
| Not yet recruiting | N/A | 50 | RoW | PEG-rhG-CSF, rhG-CSF | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd., Beijing Friendship Hospital | Hemophagocytic Syndrome | 08/21 | 09/22 | | |
NCT04782674: Study on the Application of Saliva EBV-DNA Detection in EBV Infection Related Diseases |
|
|
| Recruiting | N/A | 40 | RoW | Saliva Testing | Beijing Friendship Hospital | EBV Infection | 04/22 | 04/22 | | |
NCT05164978: DEP Combine With PD-1 Antibody as an Treatment for EBV-HLH |
|
|
| Recruiting | N/A | 20 | RoW | DEP combine with PD-1 antibody, DEP+PD-1 | Beijing Friendship Hospital | Hemophagocytic Lymphohistiocytosis | 01/23 | 01/23 | | |
| Not yet recruiting | N/A | 20 | RoW | Toripalimab Injection | Beijing Friendship Hospital | PD-1 Antibody, Mixed Chimerism | 01/23 | 05/23 | | |
NCT06313307: The Efficacy in Treatment of Facial Melasma Combined With Thulium 1927-nm Fractional Laser and Topical H2R Antagonist |
|
|
| Completed | N/A | 16 | RoW | topical H2R antagonist, Thulium 1927-nm Fractional Laser | Second Affiliated Hospital of Xi'an Jiaotong University | Melasma | 11/23 | 11/23 | | |
NCT05137522: Chidamide Combines With VP-16 and Methylprednisolone in the Treatment of HLH |
|
|
| Recruiting | N/A | 20 | RoW | Chidamide combines with VP-16 and methylprednisolone | Beijing Friendship Hospital | Chidamide, Hemophagocytic Lymphohistiocytosis | 07/23 | 07/23 | | |
NCT05532826: Clinical Study of Donor EBV-CTL Infusion in Patients With CAEBV and EBV-HLH After Allo-HSCT |
|
|
| Recruiting | N/A | 15 | RoW | donor EBV-specific T lymphocytes | Beijing Friendship Hospital | Chronic Active Epstein-Barr Virus Infection, Virus-Associated Hemophagocytic Syndrome | 09/23 | 09/24 | | |
NCT06131489: Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement |
|
|
| Not yet recruiting | N/A | 20 | RoW | Segmental bowel resection combined with the DEP regimen | Beijing Friendship Hospital | Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus, Bowel Resection | 12/26 | 01/27 | | |
NCT05841342: Prospective Study of Immune Function and PD-1 Antibody Therapy Efficacy Predictors on CAEBV and EBV-HLH Patients |
|
|
| Recruiting | N/A | 128 | RoW | No intervention | Beijing Friendship Hospital | Secondary Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection | 04/24 | 06/24 | | |
NCT05854225: Thiotepa Incorporating TBI/Cy Conditioning Regimen for EBV-HLH With Central Nervous System Involvement |
|
|
| Recruiting | N/A | 20 | RoW | Thiotepa, TT | Beijing Friendship Hospital | HLH | 06/24 | 01/25 | | |
LEAP-Block, NCT04730921: Impact of Left Bundle Branch Area Pacing vs. Right Ventricular Pacing in Atrioventricular Block |
|
|
| Recruiting | N/A | 458 | RoW | Left bundle branch area pacing, Right ventricular pacing | Fu Wai Hospital, Beijing, China, Beijing Anzhen Hospital, The First Affiliated Hospital of Zhengzhou University, The Second Hospital of Hebei Medical University, Fuwai Central China Cardiovascular Hospital, Tianjin Medical University General Hospital, Teda International Cardiovascular Hospital, Tianjin, China, Peking Union Medical College Hospital, Chinese Society of Cardiology, Affiliated Hospital of Qinghai University, Shanxi Cardiovascular Hospital, First Affiliated Hospital of Chongqing Medical University, Peking University First Hospital, Beijing Friendship Hospital | Atrioventricular Block, Left Bundle Branch Area Pacing, Right Ventricular Pacing, Heart Failure | 06/24 | 12/25 | | |
NCT06048107: Teniposide Incorporating Bu/Cy Conditioning Regimen for HLH With Central Nervous System Involvemen |
|
|
| Recruiting | N/A | 20 | RoW | Teniposide, VM-26 | Beijing Friendship Hospital | HLH | 09/24 | 09/25 | | |
NCT06727669: Longitudinal Cohort of Thrombosis and Hemostasis Diseases |
|
|
| Recruiting | N/A | 3000 | RoW | | Peking University People's Hospital | Immune Thrombocytopenia, Thrombotic Thrombocytopenic Purpura, Hemophilia A, Acquired, Disseminated Intravascular Coagulation, Thrombophilia, Deep Vein Thrombosis, Pulmonary Embolism, Thrombotic Microangiopathies, Coagulation Factor Deficiency, Hemophilia A, Hemophilia B, Hemophilia B, Acquired, Platelet Dysfunction, Arterial Thromboembolism, Bleeding Disorder, Thrombosis | 12/29 | 12/30 | | |
NCT05988177: Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections |
|
|
| Not yet recruiting | N/A | 20 | RoW | Carrimycin tablets, Carrimycin | Beijing Friendship Hospital | Carbapenem Resistant Bacterial Infection, Hemophagocytic Lymphohistiocytoses | 08/26 | 12/26 | | |
NCT05677178: Response Prediction in EBV-HLH Using Metabonomics Analysis |
|
|
| Not yet recruiting | N/A | 30 | RoW | observational | Beijing Friendship Hospital | Hemophagocytic Lymphohistiocytoses, EBV, Metabonomics | 12/24 | 03/25 | | |
NCT05600959: Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH |
|
|
| Not yet recruiting | N/A | 60 | RoW | cytokine | Beijing Friendship Hospital | Hemophagocytic Lymphohistiocytoses, Lymphoma | 11/25 | 12/25 | | |
| Mao, Min |
TE-ITP, NCT05583838: A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts |
|
|
| Completed | 4 | 157 | RoW | rhTPO, Recombinant human thrombopoietin, TPIAO, Eltrombopag, Eltrombopag olamine | Institute of Hematology & Blood Diseases Hospital, China, The Second Hospital of Hebei Medical University, Xijing Hospital, The Affiliated Hospital of Inner Mongolia Medical University, The Second Affiliated Hospital of Kunming Medical University, Second Affiliated Hospital of Guangzhou Medical University, Shaanxi Provincial People's Hospital, Henan Cancer Hospital, North China University of Science and Technology Affiliated Hospital, The Second Affiliated Hospital of Dalian Medical University, Second Hospital of Shanxi Medical University, The Second Affiliated Hospital of Harbin Medical University, Shenyang Sunshine Pharmaceutical Co., LTD., First Affiliated Hospital of Xinjiang Medical University, People's Hospital of Xinjiang Uygur Autonomous Region, Kashgar 1st People's Hospital, Xi'an Central Hospital, Beijing Public Health Foundation, Yuyao People's Hospital of Zhejiang Province | Previously Treated Primary Immune Thrombocytopenia | 02/24 | 07/24 | | |
| Wang, Feiyan |
NCT05772871: The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children |
|
|
| Recruiting | 4 | 402 | RoW | Huaiqihuang granule, Prednisone, Levamisole placebo, Levamisole, Huaiqihuang Granule placebo | Jianhua Zhou, LinkDoc Technology (Beijing) Co. Ltd. | Nephrotic Syndrome in Children | 09/25 | 10/25 | | |
